The primary purpose of the clinical investigation is to verify the SpO2 accuracy of the Philips AlarX5 SpO2 sensor with Nellcor OxiMax SpO2 Board.
Participant must have the ability to understand and provide written informed consent
Participant is an adult between 18-50 years of age
Participant must be willing and able to comply with study procedures and duration
Participant is a non-smoker or who has not smoked within 2 days prior to the study
Participant is considered as being morbidly obese (defined as BMI >39.5)
Compromised circulation (i.e., Raynaud's Syndrome), injury, or physical malformation of fingers, hands, nose, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study. Tattoos (e.g. permanent, Henna) or artificial dyes (e.g. spray tan, artificial tanning lotion) in the optical path which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow participants to participate if the condition is noted and would not affect the sites utilized.)
Females who are pregnant
Females who are trying to get pregnant with confirmation of positive urine pregnancy test